FFF Enterprises Signs Three-Year Flu Vaccine Distribution Agreement With Novartis Vaccines (Formerly Chiron)
Posted on: Thursday, 27 April 2006, 18:00 CDT
TEMECULA, Calif., April 27 /PRNewswire/ -- FFF Enterprises Inc., a multidimensional healthcare corporation based in Temecula, Calif., today announced a three-year agreement with Novartis Vaccines (formerly Chiron) for the distribution of their influenza vaccine, Fluvirin(R).
"This contract represents a key strategic relationship for FFF as the nation's leader in flu vaccine distribution," said Patrick M. Schmidt, president and CEO of FFF Enterprises. "Our goal is to ensure that as many people as possible are protected from the influenza virus."
Fluvirin will be available through FFF's traditional flu vaccine program and through its new program, MyFluVaccine at http://www.myfluvaccine.com/. "With the launch of MyFluVaccine on May 3, we are looking forward to resolving the uncertainty of when vaccine will be available," said Schmidt. "Unlike other flu vaccine distribution models, MyFluVaccine allows vaccine providers to order a dedicated supply of the product for delivery on the dates they choose. We believe this is a first in the nation."
FFF Enterprises' unique distribution model entails purchasing flu vaccine -- and all the biopharmaceutical products FFF distributes -- from manufacturers only and shipping only to healthcare providers. This protects the vaccine, and the patients who receive it, from the risks of counterfeiting, tampering, mishandling and irresponsible pricing inherent in secondary and gray pharmaceutical supply channels.
For more information, contact FFF at 800-843-7477 or visit http://www.fffenterprises.com/ and http://www.myfluvaccine.com/.
About FFF Enterprises
FFF Enterprises, founded in 1988, is a multidimensional healthcare company, delivering innovative solutions in biopharmaceutical management and distribution, health information management and consumer healthcare services. FFF is the nation's largest supplier of biopharmaceuticals, plasma products, vaccines and clinical trial drugs. Customers of FFF's four divisions include members of the leading U.S. acute care and non-acute care group purchasing organizations, government agencies, pharmaceutical manufacturers, contract research organizations, managed healthcare and consumers.
FFF's unique distribution business model has institutionalized Guaranteed Channel Integrity(TM), which reflects the company's commitment to purchase only from manufacturers and ship only to healthcare providers. This protects products from secondary and gray markets and promotes patient safety.
Contact: Kit-Bacon Gressitt VP of Communications 800-843-7477 x1143 C: 760-522-1064
FFF Enterprises Inc.
CONTACT: Kit-Bacon Gressitt, VP of Communications, +1-800-843-7477, ext.1143, or cell, +1-760-522-1064
Web site: http://www.myfluvaccine.com/http://www.fffenterprises.com/
Source: PRNewswire
Related Articles
- China America Holdings Aohong Subsidiary to Distribute Refrigeration Lubricant Products Manufactured By CPI Engineering Services, Inc.
- OHT and Health Agencies to Develop Common Healthcare IT Products
- Global HIV Vaccine Enterprise Names Alan Bernstein As Inaugural Executive Director, Opens New Secretariat
- Statement of the Forest Products Industry National Labor Management Committee on the BLM's New Forest Management Plans for Western Oregon
- FFF Enterprises Awarded State of California Flu Vaccine Contract for 2006-2007 Flu Season
- Netherlands Begins Vaccination of Chickens Against Bird Flu
- New Vaccines Necessary for New Bird Flu Strain: U.S. Official
- 43 Tons of Chinese Vaccines Help Vietnam Combat Bird Flu
- Biosecurity, Vaccine Screenings Prioritized Against Bird Flu in Indonesia
 |
 |
User Comments (0)
RSS Feeds